The relationship between cognition and mortality in patients with stroke, coronary heart disease, or cancer

被引:31
作者
Anstey, Kaarin J. [1 ]
Mack, Holly A. [1 ]
von Sanden, Chwee [1 ]
机构
[1] Australian Natl Univ, Aging Res Unit, Mental Hlth Res Ctr, Canberra, ACT 0200, Australia
关键词
cognitive decline; mortality; coronary heart disease; cancer; stroke;
D O I
10.1027/1016-9040.11.3.182
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Numerous studies have reported an association between a cognitive impairment and an increased risk for mortality. Most results are from large epidemiological studies and control for medical conditions that may relate to cognitive decline, as well as an increased mortality risk. The aim of this review was to evaluate the association between cognitive performance and mortality within patient samples of stroke, cancer, or coronary heart disease. After reviewing the PubMed literature for articles on stroke, cancer, and cardiovascular related illness, 47 longitudinal studies were identified that met the cognition/mortality search criteria. In general, the results demonstrated that within the clinical groups studied, cognitive performance and cognitive impairment both predict mortality, although results were less consistent for coronary heart disease. This adds further support for the ubiquity of the association of congitive performance with health outcomes and mortality. Optimizing health has implications for both cognitive performance and longevity.
引用
收藏
页码:182 / 195
页数:14
相关论文
共 71 条
[41]   Brain evolution and lifespan regulation: conservation of signal transduction pathways that regulate energy metabolism [J].
Mattson, MP .
MECHANISMS OF AGEING AND DEVELOPMENT, 2002, 123 (08) :947-953
[42]   Cognitive function as a predictor of survival in patients with recurrent malignant glioma [J].
Meyers, CA ;
Hess, KR ;
Yung, WKA ;
Levin, VA .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :646-650
[43]   Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: Results of a randomized phase III trial [J].
Meyers, CA ;
Smith, JA ;
Bezjak, A ;
Mehta, MP ;
Liebmann, J ;
Illidge, T ;
Kunkler, I ;
Caudrelier, JM ;
Eisenberg, PD ;
Meerwaldt, J ;
Siemers, R ;
Carrie, C ;
Gaspar, LE ;
Curran, W ;
Phan, SC ;
Miller, RA ;
Renschler, MF .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) :157-165
[44]   The Besancon stroke registry: An acute stroke registry of 2,500 consecutive patients [J].
Moulin, T ;
Tatu, L ;
CrepinLeblond, T ;
Chavot, D ;
Berges, S ;
Rumbach, L .
EUROPEAN NEUROLOGY, 1997, 38 (01) :10-20
[45]   Importance of the Mini-Mental Status Examination in the treatment of patients with brain metastases: A report from the Radiation Therapy Oncology Group protocol 91-04 [J].
Murray, KJ ;
Scott, C ;
Zachariah, B ;
Michalski, JM ;
Demas, W ;
Vora, NL ;
Whitton, A ;
Movsas, B .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01) :59-64
[46]   Validity of the Clock-Drawing Test as a screening tool for cognitive impairment in the elderly [J].
Nishiwaki, Y ;
Breeze, E ;
Smeeth, L ;
Bulpitt, CJ ;
Peters, R ;
Fletcher, AE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (08) :797-807
[47]  
OCHIAI ME, 2004, ARQUIVOS BRASILEIROS, V82, P255
[48]   Vascular genetic factors and human longevity [J].
Panza, F ;
D'Introno, A ;
Colacicco, AM ;
Capurso, C ;
Capurso, S ;
Kehoe, PG ;
Capurso, A ;
Solfrizzi, V .
MECHANISMS OF AGEING AND DEVELOPMENT, 2004, 125 (03) :169-178
[49]   Cognitive impairment after stroke: Clinical determinants and its associations with long-term stroke outcomes [J].
Patel, MD ;
Coshall, C ;
Rudd, AG ;
Wolfe, CDA .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) :700-706
[50]   Relation between cognitive function and mortality in middle-aged adults - The Atherosclerosis Risk in Communities Study [J].
Pavlik, VN ;
de Moraes, SA ;
Szklo, M ;
Knopman, DS ;
Mosley, TH ;
Hyman, PJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (04) :327-334